Sofiva Genomics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	90.61	112.08	96.81	119.81	214.99
Short-Term Investments	34.1	34.1	43.23	51.15	30.2
Cash & Short-Term Investments	124.71	146.18	140.03	170.96	245.19
Cash Growth	-14.69%	4.39%	-18.09%	-30.27%	11.94%
Accounts Receivable	62.07	65.94	75.95	75.16	74.04
Other Receivables	4.45	4.98	9.01	7.53	4.76
Receivables	66.52	70.92	84.96	82.68	78.8
Inventory	34.85	46.4	41.79	57.08	41.56
Prepaid Expenses	8.98	7.95	8.78	10.83	6.58
Other Current Assets	1.13	1.15	1.79	2.33	1.39
Total Current Assets	236.2	272.6	277.34	323.88	373.53
Property, Plant & Equipment	68.92	103.16	116.08	129.23	128.57
Long-Term Investments	385.39	368.02	348.09	333.32	297.35
Other Intangible Assets	5.15	8.19	6.86	6.61	6.23
Long-Term Deferred Tax Assets	5.38	5.06	9.31	6.65	8.91
Other Long-Term Assets	23.31	11.06	9.45	7.87	7.72
Total Assets	724.35	768.08	767.14	807.56	822.3
Accounts Payable	22.64	22.47	31.72	50.6	58.44
Accrued Expenses	0.69	33.1	37.15	36.48	30.52
Current Portion of Leases	13.73	16.43	14.43	14.16	14.48
Current Income Taxes Payable	0.73	-	-	-	4.22
Current Unearned Revenue	1.18	1.77	0.77	2.11	2.69
Other Current Liabilities	31.93	9.68	12.12	12.64	12.99
Total Current Liabilities	70.9	83.46	96.2	115.99	123.35
Long-Term Leases	21.8	36.95	49.15	60.52	71.45
Long-Term Deferred Tax Liabilities	0.14	0.24	0.25	0.62	-
Other Long-Term Liabilities	3.08	3.03	3.17	3.12	3.06
Total Liabilities	95.91	123.68	148.77	180.24	197.86
Common Stock	215.93	215.93	213.62	213.62	213.62
Additional Paid-In Capital	242.63	341.59	332.06	330.99	328.31
Retained Earnings	70.82	86.66	72.5	82.34	82.29
Comprehensive Income & Other	98.74	-0.15	-0.05	-0.03	0.01
Total Common Equity	628.13	644.04	618.14	626.92	624.23
Minority Interest	0.31	0.36	0.23	0.4	0.21
Shareholders' Equity	628.43	644.4	618.37	627.32	624.44
Total Liabilities & Equity	724.35	768.08	767.14	807.56	822.3
Total Debt	35.53	53.38	63.59	74.67	85.94
Net Cash (Debt)	89.18	92.8	76.45	96.29	159.26
Net Cash Growth	-3.90%	21.39%	-20.61%	-39.54%	35.02%
Net Cash Per Share	4.10	4.29	3.58	4.50	7.48
Filing Date Shares Outstanding	22.29	21.59	21.36	21.36	21.36
Total Common Shares Outstanding	22.29	21.59	21.36	21.36	21.36
Working Capital	165.3	189.14	181.14	207.89	250.18
Book Value Per Share	28.18	29.83	28.94	29.35	29.22
Tangible Book Value	622.98	635.85	611.28	620.3	618
Tangible Book Value Per Share	27.95	29.45	28.61	29.04	28.93
Machinery	-	167.48	157.43	144.6	115.73
Leasehold Improvements	-	28.15	28.33	29.91	29.33

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.